| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 09/29/2009 | US7595038 Methods of treatment using antibodies to follistatin-3 |
| 09/29/2009 | CA2446741C Ophthalmic drug delivery device |
| 09/29/2009 | CA2404163C Production of recombinant blood clotting factors in human cell lines |
| 09/29/2009 | CA2293489C Inhibitors of dna immunostimulatory sequence activity |
| 09/29/2009 | CA2250118C Method enabling use of extracellular rna extracted from plasma or serum to detect, monitor or evaluate cancer |
| 09/29/2009 | CA2240737C A long qt syndrome gene which encodes kvlqt1 and its association with mink |
| 09/29/2009 | CA2227284C A process for preparing microparticles through phase inversion phenomena |
| 09/29/2009 | CA2194660C Growth differentiation factor-11 |
| 09/29/2009 | CA2184297C Recombinant viruses coding for a glutamate decarboxylase (gad) activity |
| 09/24/2009 | WO2009117736A2 Avian virus vaccines and uses thereof |
| 09/24/2009 | WO2009117656A2 Capsid-incorporated antigen for novel adenovirus vaccine |
| 09/24/2009 | WO2009117566A1 Chemokine gene-modified cells for cancer immunotherapy |
| 09/24/2009 | WO2009117553A2 Enhancing vessel lesion homing and repair potential of stem cells |
| 09/24/2009 | WO2009117418A2 Identification of micro-rnas involved in neuromuscular synapse maintenance and regeneration |
| 09/24/2009 | WO2009117188A2 Stabilization of macromolecular membranes |
| 09/24/2009 | WO2009117116A2 Heat shock protein gp96 vaccination and methods of using same |
| 09/24/2009 | WO2009117011A1 Tumor cell vaccines |
| 09/24/2009 | WO2009116257A1 Therapeutic agent for fibroid lung |
| 09/24/2009 | WO2009116037A2 NOVEL siRNA COMPOUNDS FOR INHIBITING RTP801 |
| 09/24/2009 | WO2009115579A1 Biodegradable nanoshells for delivery of therapeutic and/or imaging molecules |
| 09/24/2009 | WO2009115465A1 Synthetic phosphodiester oligonucleotides and therapeutical uses thereof |
| 09/24/2009 | WO2009114942A1 Thymidylate kinase fusions and uses thereof |
| 09/24/2009 | WO2009081065A3 Method of preparing a material formed from branched molecules comprising associative groups |
| 09/24/2009 | WO2009070805A3 Mir-124 regulated genes and pathways as targets for therapeutic intervention |
| 09/24/2009 | WO2009035160A8 Candidate molecule for falciparum malaria vaccine |
| 09/24/2009 | US20090239939 Combinations for introducing nucleic acids into cells |
| 09/24/2009 | US20090239938 Preventive/remedy for arteriosclerosis |
| 09/24/2009 | US20090239815 Novel human microRNAs associated with cancer |
| 09/24/2009 | US20090239220 Dlc-1 gene deleted in cancers |
| 09/24/2009 | US20090239219 Telomerase expression repressor proteins and methods of using the same |
| 09/24/2009 | US20090238883 Liver-specific nanocapsules and methods of using |
| 09/24/2009 | US20090238864 Dna vaccines encoding heat shock proteins |
| 09/24/2009 | US20090238841 Hiv vaccine formulations |
| 09/24/2009 | US20090238802 Intraperitoneal Delivery Of Genetically Engineered Mesenchymal Stem Cells |
| 09/24/2009 | US20090238795 In vivo and ex vivo gene transfer into renal tissue using gutless adenovirus vectors |
| 09/24/2009 | US20090238774 Use of lactic acid bacteria for decreasing gum bleeding and reducing oral inflammation |
| 09/24/2009 | DE102008013623A1 Pharmazeutische Zusammensetzung zur Diagnose oder Behandlung von Zinkfinger Protein assoziierten Erkrankungen A pharmaceutical composition for diagnosis or treatment of diseases associated zinc finger protein |
| 09/24/2009 | CA2718961A1 Enhancing vessel lesion homing and repair potential of stem cells |
| 09/24/2009 | CA2718884A1 Heat shock protein gp96 vaccination and methods of using same |
| 09/24/2009 | CA2718765A1 Novel sirna compounds for inhibiting rtp801 |
| 09/24/2009 | CA2718560A1 Therapeutic agent for fibroid lung |
| 09/24/2009 | CA2718520A1 Identification of micro-rnas involved in neuromuscular synapse maintenance and regeneration |
| 09/24/2009 | CA2712705A1 Synthetic phosphodiester oligonucleotides and therapeutical uses thereof |
| 09/23/2009 | EP2103689A1 Synthetic phosphodiester oligonucleotides and therapeutical uses thereof |
| 09/23/2009 | EP2102340A2 Methods for treating hypercholesterolemia |
| 09/23/2009 | EP2101823A2 Rna-coded antibody |
| 09/23/2009 | EP1567539B1 Allele-specific rna interference |
| 09/23/2009 | EP1542528B1 A method of treatment and prophylaxis |
| 09/23/2009 | EP1423504B1 Compositions and methods for isolation, propagation, and differentiation of non-embryonic human stem cells and uses thereof |
| 09/23/2009 | EP1003781B1 Interleukin-18 binding proteins, their preparation and use |
| 09/23/2009 | CN101538574A Codon-optimized cholera enterotoxin CTB gene and cholera nucleic acid vaccine thereof |
| 09/23/2009 | CN101538569A RNA and recombinant for inhibiting human DMT1 protein and application thereof |
| 09/23/2009 | CN101538568A RNA and recombinant for inhibiting human ferroportin and application thereof |
| 09/23/2009 | CN101538557A Recombinant human divalent metal ion transporter adenovirusm and preparation method and application thereof |
| 09/23/2009 | CN101538556A Method for replicating adenovirus by way of selection and mutual compensation |
| 09/23/2009 | CN101537191A Recomposed tPA gene-chitosan nanoparticle complex and preparation method thereof |
| 09/23/2009 | CN101537015A Application of carbon nano-tubes in immunity accelerators for preparing anti-tumor immunotherapy medicaments |
| 09/23/2009 | CN100542614C Virus envelope vector for gene transfer |
| 09/23/2009 | CN100542605C Nucleic acid coated particles |
| 09/22/2009 | US7592446 Synthesis of selenium-derivatized nucleosides, nucleotides, phosphoramidites, triphosphates and nucleic acids |
| 09/22/2009 | US7592444 siRNA targeting myeloid cell leukemia sequence 1 |
| 09/22/2009 | US7592441 miRNA for diagnosis, prognosis, and treatment of liver cancer |
| 09/22/2009 | US7592438 Human gene |
| 09/22/2009 | US7592437 Genes involved in intestinal inflammatory diseases and use thereof |
| 09/22/2009 | US7592323 Testosterone-repressed prostate message-2 (TRPM-2); delaying progression of prostatic tumor cells to an androgen-independent state |
| 09/22/2009 | US7592321 Preventing/inhibiting metabolic disorders characterized by absence or reduced levels of alpha-L-iduronidase in newborn mammals by administering recombinant lentivirus comprising nucleic acid segment encoding alpha-L-iduronidase |
| 09/22/2009 | US7592320 Messenger RNA sequence comprising translatable sequence encoding toxin and untranslated sequence which inhibits translation of toxin sequence under conditions existing within mammalian cells that overexpress eukaryotic initiation factor eIF4 |
| 09/22/2009 | US7592176 Method of forming mesenchymal stem cells from embryonic stem cells |
| 09/22/2009 | US7592170 Selective precipitation of viruses using polyectrolytes |
| 09/22/2009 | US7592149 Can be used to elicit a humoral or cellular immune response; antibodies or T cells reactive with 184P1E2 can be used in active or passive immunization |
| 09/22/2009 | US7592013 Administering a recombant food-grade bacterium expressing a trefoil peptide;delivering a TFF1 trefoil peptide in vivo expressed by a Lactococcus for lesion damage to the mucous membranes of the mouth caused by radiation; antinflammatory agents; gastrointestinal disorders |
| 09/17/2009 | WO2009114878A2 Methods and compositions for genetic and retinal disease |
| 09/17/2009 | WO2009114817A2 Pttg1 as a biomarker for cancer treatment |
| 09/17/2009 | WO2009114703A2 Combination therapy for the treatment of cancer |
| 09/17/2009 | WO2009114700A2 Cell model of neurodegenerative disease and methods of use thereof for identifying inhibitors of mitochondrial fusion |
| 09/17/2009 | WO2009114681A2 Identification of mirna profiles that are diagnostic of hypertrophic cardiomyopathy |
| 09/17/2009 | WO2009114614A2 Compositions and methods for controlled delivery of inhibitory ribonucleic acids |
| 09/17/2009 | WO2009114487A2 Use of sirna to achieve down regulation of an endogenous gene in combination with the use of a sense construct to achieve expression of a desired polynucleotide |
| 09/17/2009 | WO2009114459A2 Anti-neoplastic combination therapeutic regimen involving co-disruption of parp pathway and mre11/rad50/nbs1 complex and compositons useful therein |
| 09/17/2009 | WO2009113579A1 Double-stranded nucleic acid molecule suitable for prevention or treatment of cancer, cancer cell proliferation inhibitor, and pharmaceutical preparation |
| 09/17/2009 | WO2009113295A1 C2orf18 as target gene for cancer therapy and diagnosis |
| 09/17/2009 | WO2009112402A1 Polymer derived from linear polyethylenimine for gene transfer |
| 09/17/2009 | US20090233992 Hepatitis c virus vaccine |
| 09/17/2009 | US20090233983 RNA Interference Mediated Inhibition of Protein Tyrosine Phosphatase-1B (PTP-1B) Gene Expression Using Short Interfering RNA |
| 09/17/2009 | US20090233871 Complexed polypeptide and adjuvant for improved vaccines |
| 09/17/2009 | US20090233857 Dna vaccine compositions and methods of use |
| 09/17/2009 | US20090233855 Compounds and methods for modulating activation of nf-kb |
| 09/17/2009 | US20090233848 Pea15 as a Tumor Suppressor Gene |
| 09/17/2009 | US20090233368 Allele suppression |
| 09/17/2009 | US20090233354 Multipotent adult stem cells and methods for isolation |
| 09/17/2009 | US20090233353 Multipotent adult stem cells and methods for isolation |
| 09/17/2009 | US20090233270 Secreted and cytoplasmic tumor endothelial markers |
| 09/17/2009 | US20090232825 Methods and Compositions For Modulating Immunity |
| 09/17/2009 | US20090232809 Type 2 cytokine receptor and nucleic acids encoding same |
| 09/17/2009 | US20090232791 comprising a first component comprising fibrinogen, aprotinin, and a buffered solution, and comprising, fibroblasts, keratinocytes, thrombin, glycerol, human serum albumin, and a buffered solution, wherein components are comprised in separate sterile containers |
| 09/17/2009 | DE102008013622A1 Pharmazeutische Zusammensetzung zur Diagnose oder Behandlung des Plasmozytoms A pharmaceutical composition for the diagnosis or treatment of multiple myeloma |
| 09/17/2009 | CA2718495A1 Recombinant production of authentic human proteins using human cell expression systems |
| 09/17/2009 | CA2717778A1 Polymer derived from linear polyethylenimine for gene transfer |
| 09/17/2009 | CA2717637A1 Use of sirna to achieve down regulation of an endogenous gene in combination with the use of a sense construct to achieve expression of a desired polynucleotide |
| 09/16/2009 | EP2100620A1 Nucleic acids encoding polyepitope polypeptides |